Gary L Darmstadt1, Naila Z Khan2, Summer Rosenstock3, Humaira Muslima2, Monowara Parveen2, Wajeeha Mahmood4, A S M Nawshad Uddin Ahmed5, M A K Azad Chowdhury5, Scott Zeger6, Samir K Saha7,8. 1. Prematurity Research Center, Division of Neonatal and Developmental Medicine, Department of Pediatrics, Stanford University School of Medicine, 1701 Page Mill Road, Palo Alto, CA, 94304, USA. gdarmsta@stanford.edu. 2. Clinical Neurosciences Center, Bangladesh Protibondhi Foundation, Dhaka, Bangladesh. 3. Center for American Indian Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 4. Prematurity Research Center, Division of Neonatal and Developmental Medicine, Department of Pediatrics, Stanford University School of Medicine, 1701 Page Mill Road, Palo Alto, CA, 94304, USA. 5. Department of Neonatology, Bangladesh Institute of Child Health, Dhaka Shishu Hospital, Dhaka, Bangladesh. 6. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 7. Department of Microbiology, Bangladesh Institute of Child Health, Dhaka Shishu Hospital, Dhaka, Bangladesh. 8. Child Health Research Foundation , Dhaka, Bangladesh.
Abstract
BACKGROUND: Topical treatment with sunflower seed oil (SSO) or Aquaphor® reduced sepsis and neonatal mortality in hospitalized preterm infants <33 weeks' gestational age in Bangladesh. We sought to determine whether the emollient treatments improved neurodevelopmental outcomes during early childhood. METHODS:497 infants were randomized to receive SSO, Aquaphor®, or neither through the neonatal period or hospital discharge. 159 infant survivors were enrolled in the longitudinal follow-up study using a validated Rapid Neurodevelopmental Assessment tool and the Bayley Scales of Infant Development II (BSID II) administered at three-monthly intervals for the first year and thereafter at six-monthly intervals. Lowess smoothing was used to display neurodevelopmental status across multiple domains by age and treatment group, and Generalized Estimating Equations (GEE) were used to compare treatment groups across age points. RESULTS:123 children completed at least one follow-up visit. Lowess graphs suggest that lower proportions of children who received massage with either SSO or Aquaphor® had neurodevelopmental delays than control infants in a composite outcome of disabilities. In GEE analysis, infants receiving SSO showed a significant protective effect on the development of fine motor skills [odds ratio (OR) 0.92, 95% confidence interval (CI) 0.86-0.98, p=0.006]. The Psychomotor Development Index (PDI) in the BSID II showed significantly lower disability rates in the Aquaphor group (23.6%) compared to the control (55.2%) (OR 0.21, 95% CI 0.06-0.72, p=0.004). CONCLUSIONS:Emollient massage of very preterm, hospitalized newborn infants improved some child neurodevelopmental outcomes over the first 2 years of follow-up. Findings warrant further confirmatory research. TRIAL REGISTRATION: ClinicalTrials.gov (98-04-21-03-2) under weblink https://clinicaltrials.gov/ct2/show/NCT00162747.
RCT Entities:
BACKGROUND: Topical treatment with sunflower seed oil (SSO) or Aquaphor® reduced sepsis and neonatal mortality in hospitalized preterm infants <33 weeks' gestational age in Bangladesh. We sought to determine whether the emollient treatments improved neurodevelopmental outcomes during early childhood. METHODS: 497 infants were randomized to receive SSO, Aquaphor®, or neither through the neonatal period or hospital discharge. 159 infant survivors were enrolled in the longitudinal follow-up study using a validated Rapid Neurodevelopmental Assessment tool and the Bayley Scales of Infant Development II (BSID II) administered at three-monthly intervals for the first year and thereafter at six-monthly intervals. Lowess smoothing was used to display neurodevelopmental status across multiple domains by age and treatment group, and Generalized Estimating Equations (GEE) were used to compare treatment groups across age points. RESULTS: 123 children completed at least one follow-up visit. Lowess graphs suggest that lower proportions of children who received massage with either SSO or Aquaphor® had neurodevelopmental delays than control infants in a composite outcome of disabilities. In GEE analysis, infants receiving SSO showed a significant protective effect on the development of fine motor skills [odds ratio (OR) 0.92, 95% confidence interval (CI) 0.86-0.98, p=0.006]. The Psychomotor Development Index (PDI) in the BSID II showed significantly lower disability rates in the Aquaphor group (23.6%) compared to the control (55.2%) (OR 0.21, 95% CI 0.06-0.72, p=0.004). CONCLUSIONS: Emollient massage of very preterm, hospitalized newborn infants improved some child neurodevelopmental outcomes over the first 2 years of follow-up. Findings warrant further confirmatory research. TRIAL REGISTRATION: ClinicalTrials.gov (98-04-21-03-2) under weblink https://clinicaltrials.gov/ct2/show/NCT00162747.
Authors: Maureen M Black; Susan P Walker; Lia C H Fernald; Christopher T Andersen; Ann M DiGirolamo; Chunling Lu; Dana C McCoy; Günther Fink; Yusra R Shawar; Jeremy Shiffman; Amanda E Devercelli; Quentin T Wodon; Emily Vargas-Barón; Sally Grantham-McGregor Journal: Lancet Date: 2016-10-04 Impact factor: 79.321
Authors: Joy E Lawn; Hannah Blencowe; Shefali Oza; Danzhen You; Anne C C Lee; Peter Waiswa; Marek Lalli; Zulfiqar Bhutta; Aluisio J D Barros; Parul Christian; Colin Mathers; Simon N Cousens Journal: Lancet Date: 2014-05-19 Impact factor: 79.321
Authors: Li Liu; Shefali Oza; Daniel Hogan; Jamie Perin; Igor Rudan; Joy E Lawn; Simon Cousens; Colin Mathers; Robert E Black Journal: Lancet Date: 2014-09-30 Impact factor: 79.321
Authors: Vishwajeet Kumar; Aarti Kumar; Shambhavi Mishra; Peiyi Kan; Sana Ashraf; Shambhavi Singh; Keona J H Blanks; Michael Baiocchi; Mika Limcaoco; Amit K Ghosh; Alok Kumar; Raghav Krishna; David K Stevenson; Lu Tian; Gary L Darmstadt Journal: Am J Clin Nutr Date: 2022-04-01 Impact factor: 7.045
Authors: K M Shahunja; Daniel C Sévin; Lindsay Kendall; Tahmeed Ahmed; Md Iqbal Hossain; Mustafa Mahfuz; Xinyi Zhu; Krishan Singh; Sunita Singh; Jonathan M Crowther; Rachel A Gibson; Gary L Darmstadt Journal: Nutr J Date: 2021-06-06 Impact factor: 3.271
Authors: Aarti Kumar; Shambhavi Mishra; Shambhavi Singh; Sana Ashraf; Peiyi Kan; Amit Kumar Ghosh; Alok Kumar; Raghav Krishna; David K Stevenson; Lu Tian; Peter M Elias; Gary L Darmstadt; Vishwajeet Kumar Journal: PLoS Med Date: 2021-09-28 Impact factor: 11.069